The Clearity Foundation - Improving treatment options for ovarian cancer patients First Event in Clearity’s Personalized Medicine Series: Personalized Medicine Is Failing Patients How can we make it work?

The Clearity Foundation's Personalized Medicine Symposium Series will create a venue for productive discussion of the challenges and opportunities in bringing the promise of personalized medicine to reality. Personalized medicine will require an integrated approach to leverage breakthrough technical advances with the practical realities of providing solutions to patients, physicians, and payers. This event will draw from the wisdom and experience of three top innovators who are at the front lines of bringing personalized medicine to reality. Please join us for an outstanding panel presentation, networking, discussion, drinks and appetizers.

Moderated by David Nelson, PhD, Epic Sciences

Panel Presentations by:
Michael Pellini, MD, President & Chief Executive Officer, Foundation Medicine
Ronnie Andrews, President, Medical Sciences, Life Technologies
Peter Kuhn, PhD, Assoc Professor of Cell Biology, The Scripps Research Institute

Tuesday, October 23, 2012
3535 General Atomics Court
San Diego, CA 92121
5:00 - 7:30pm
$50 registration
RSVP: Please email patpio@clearityfoundation.org
Twitter: #pmsymposium

 
Celgene CanaleComm Taylor & Pond
RP & A
Epic Sciences DLA Piper Foundation Medicine
Sanford Rose Associates BioCom Gen-Probe
Marshall Edwards Inc Davenport Manor RP & A
RP & ARP & ARP & A
  The Clearity Foundation is the only foundation in America dedicated to improving therapeutic options for women with ovarian cancer now. We believe we are the first organization making personalized medicine a reality for women with this disease. By improving the information used in making treatment decisions, our goal is for women with ovarian cancer to live longer, healthier lives. More at www.clearityfoundation.org.